Persistent Identifier
|
doi:10.7910/DVN/EULHTX |
Publication Date
|
2017-09-06 |
Title
| New antigens for multi-component blood-stage vaccines against Plasmodium falciparum malaria |
Author
| Osier, FaithBioscience department, Kenya Medical Research Institute - Centre of Geographical Medicine Research, Coast, Post Office Box 230-80108, Kilifi, KenyaORCID0000-0001-7133-5375
Kamuyu, GathoniBioscience department, Kenya Medical Research Institute - Centre of Geographical Medicine Research, Coast, Post Office Box 230-80108, Kilifi, KenyaORCID0000-0001-5688-7657
Crosnier, CécileCell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge CB10 1HH, UK; Malaria programme, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK
Wanaguru, MadushiCell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge CB10 1HH, UK; Malaria programme, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK
Oganda, EdnaBioscience department, Kenya Medical Research Institute - Centre of Geographical Medicine Research, Coast, Post Office Box 230-80108, Kilifi, Kenya
McDade, BrianCell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge CB10 1HH, UK |
Point of Contact
|
Use email button above to contact.
Osier, Faith (Bioscience department, Kenya Medical Research Institute - Centre of Geographical Medicine Research, Coast, Post Office Box 230-80108, Kilifi, Kenya) |
Description
| This dataset is from a prospective longitudinal cohort study of children from Chonyi village in Kilifi County, Kenya. The study was conducted for the purpose of evaluating the potential protective efficacy of antibodies to Plasmodium falciparum antigens against clinical episodes of malaria. Venous blood was collected from 286 children (age 1-10 years old) during a cross-sectional survey at the start of a malaria transmission season. Thick and thin blood smears were prepared for parasite detection by microscopy. Plasma was used to measure antibody levels to 39 Plasmodium falciparum merozoite surface and secreted proteins by enzyme linked immunosorbent assay. The children were then followed up for a period of 6 months with both active (Weekly home visits) and passive surveillance for malaria case detection. |
Subject
| Medicine, Health and Life Sciences |
Keyword
| Malaria
Merozoite
Plasmodium falciparum
Immunity
Vaccine |
Related Publication
| Osier, F. H., M. J. Mackinnon, C. Crosnier, G. Fegan, G. Kamuyu, M. Wanaguru, E. Ogada, B. McDade, J. C. Rayner, G. J. Wright and K. Marsh (2014). "New antigens for a multicomponent blood-stage malaria vaccine." Sci Transl Med 6(247): 247ra102.10. DOI: 1126/scitranslmed.3008705 URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856877/ doi 1126/scitranslmed.3008705 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856877/ |
Depositor
| Osier, Faith |
Deposit Date
| 2017-08-06 |